388 related articles for article (PubMed ID: 9626825)
1. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
[TBL] [Abstract][Full Text] [Related]
5. Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
White HD; Ellis CJ; French JK; Aylward P
Aust N Z J Med; 1998 Aug; 28(4):551-4. PubMed ID: 9777138
[TBL] [Abstract][Full Text] [Related]
6. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
7. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Antman EM
Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
[TBL] [Abstract][Full Text] [Related]
9. The GUSTO 2b and related studies. Global Use of Strategies to Open Occluded Coronary Arteries.
Aylward P
Aust N Z J Med; 1998 Aug; 28(4):548-50. PubMed ID: 9777137
[TBL] [Abstract][Full Text] [Related]
10. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
White HD
Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
[TBL] [Abstract][Full Text] [Related]
11. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
[TBL] [Abstract][Full Text] [Related]
12. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
13. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators.
Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD
Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216
[TBL] [Abstract][Full Text] [Related]
14. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
17. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B
Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184
[TBL] [Abstract][Full Text] [Related]
19. Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis.
Martin U; Dörge L; Fischer S
Br J Pharmacol; 1996 May; 118(2):271-6. PubMed ID: 8735626
[TBL] [Abstract][Full Text] [Related]
20. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
